These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 8071110)
41. Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats. Yoshimi N; Kawabata K; Hara A; Matsunaga K; Yamada Y; Mori H Jpn J Cancer Res; 1997 Nov; 88(11):1044-51. PubMed ID: 9439679 [TBL] [Abstract][Full Text] [Related]
42. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Tanaka T; Kohno H; Yoshitani S; Takashima S; Okumura A; Murakami A; Hosokawa M Cancer Res; 2001 Mar; 61(6):2424-8. PubMed ID: 11289109 [TBL] [Abstract][Full Text] [Related]
43. Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon. Morishita Y; Yoshimi N; Kawabata K; Matsunaga K; Sugie S; Tanaka T; Mori H Jpn J Cancer Res; 1997 Sep; 88(9):815-20. PubMed ID: 9369928 [TBL] [Abstract][Full Text] [Related]
44. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Tanaka T; Kawabata K; Kakumoto M; Hara A; Murakami A; Kuki W; Takahashi Y; Yonei H; Maeda M; Ota T; Odashima S; Yamane T; Koshimizu K; Ohigashi H Cancer Res; 1998 Jun; 58(12):2550-6. PubMed ID: 9635577 [TBL] [Abstract][Full Text] [Related]
45. Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPARgamma expression and alteration of lipid composition. Kohno H; Yasui Y; Suzuki R; Hosokawa M; Miyashita K; Tanaka T Int J Cancer; 2004 Jul; 110(6):896-901. PubMed ID: 15170673 [TBL] [Abstract][Full Text] [Related]
47. Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence. Raju J; Swamy MV; Cooma I; Patlolla JM; Pittman B; Reddy BS; Steele VE; Rao CV Int J Cancer; 2005 Feb; 113(5):798-802. PubMed ID: 15499611 [TBL] [Abstract][Full Text] [Related]
48. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats. Patlolla JM; Zhang Y; Li Q; Steele VE; Rao CV Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158 [TBL] [Abstract][Full Text] [Related]
49. A ferulic acid derivative, ethyl 3-(4'-geranyloxy-3-methoxyphenyl)-2-propenoate, as a new candidate chemopreventive agent for colon carcinogenesis in the rat. Han BS; Park CB; Takasuka N; Naito A; Sekine K; Nomura E; Taniguchi H; Tsuno T; Tsuda H Jpn J Cancer Res; 2001 Apr; 92(4):404-9. PubMed ID: 11346462 [TBL] [Abstract][Full Text] [Related]
50. Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Alabaster O; Tang Z; Frost A; Shivapurkar N Carcinogenesis; 1995 Jan; 16(1):127-32. PubMed ID: 7834797 [TBL] [Abstract][Full Text] [Related]
51. Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats. Ishikawa S; Asano T; Takenoshita S; Nozawa Y; Arihara K; Itoh M Nutr Res; 2009 Jan; 29(1):64-9. PubMed ID: 19185779 [TBL] [Abstract][Full Text] [Related]
52. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats. Miyamoto S; Kohno H; Suzuki R; Sugie S; Murakami A; Ohigashi H; Tanaka T Oncol Rep; 2006 May; 15(5):1169-73. PubMed ID: 16596181 [TBL] [Abstract][Full Text] [Related]
53. Effects of roselle (Hibiscus sabdariffa Linn.), a Thai medicinal plant, on the mutagenicity of various known mutagens in Salmonella typhimurium and on formation of aberrant crypt foci induced by the colon carcinogens azoxymethane and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in F344 rats. Chewonarin T; Kinouchi T; Kataoka K; Arimochi H; Kuwahara T; Vinitketkumnuen U; Ohnishi Y Food Chem Toxicol; 1999 Jun; 37(6):591-601. PubMed ID: 10478827 [TBL] [Abstract][Full Text] [Related]
54. Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Yamashita N; Minamoto T; Onda M; Esumi H Jpn J Cancer Res; 1994 Jul; 85(7):692-8. PubMed ID: 7915263 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of azoxymethane-induced colon carcinogenesis in male F344 rats by the citrus limonoids obacunone and limonin. Tanaka T; Maeda M; Kohno H; Murakami M; Kagami S; Miyake M; Wada K Carcinogenesis; 2001 Jan; 22(1):193-8. PubMed ID: 11159759 [TBL] [Abstract][Full Text] [Related]
56. Dietary folate protects against azoxymethane-induced aberrant crypt foci development and oxidative stress in rat colon. Al-Numair KS; Waly MI; Ali A; Essa MM; Farhat MF; Alsaif MA Exp Biol Med (Maywood); 2011 Sep; 236(9):1005-11. PubMed ID: 21768165 [TBL] [Abstract][Full Text] [Related]
57. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Femia AP; Dolara P; Caderni G Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897 [TBL] [Abstract][Full Text] [Related]
58. Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats. Zheng Y; Kramer PM; Olson G; Lubet RA; Steele VE; Kelloff GJ; Pereira MA Carcinogenesis; 1997 Nov; 18(11):2119-25. PubMed ID: 9395211 [TBL] [Abstract][Full Text] [Related]
59. Effect of calcium on azoxymethane-induced aberrant crypt foci and cell proliferation in the colon of rats. Li H; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA Cancer Lett; 1998 Feb; 124(1):39-46. PubMed ID: 9500189 [TBL] [Abstract][Full Text] [Related]
60. Effects of resistant starch on colonic preneoplastic aberrant crypt foci in rats. Liu R; Xu G Food Chem Toxicol; 2008 Aug; 46(8):2672-9. PubMed ID: 18571825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]